For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
First-Ever Drug for Alzheimer's Agitation, Brexpiprazole, Nears
REXULTI® (brexpiprazole) agitation that may happen with dementia
JAMA Neurology Publishes Complete Results of Positive Phase 3
Lundbeck, Otsuka drug cut agitation in Alzheimer's patients
Rexulti Full Prescribing Information, Dosage & Side Effects
Otsuka Pharmaceutical and Lundbeck present positive results
Decision on Brexpiprazole for Alzheimer's Agitation Due in May
This Antipsychotic Drug Can Now Be Used to Treat Agitation in
BioXcel shares rise on result of Alzheimer's drug probe
FDA Approves the First Drug for Alzheimer's Agitation: Rexulti
de
por adulto (o preço varia de acordo com o tamanho do grupo)
